ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $309,000 | -73.4% | 48,395 | -74.0% | 0.00% | -71.4% |
| Q4 2015 | $1,162,000 | -22.5% | 185,893 | -27.6% | 0.01% | -33.3% |
| Q3 2015 | $1,499,000 | +109.7% | 256,723 | +196.9% | 0.02% | +110.0% |
| Q2 2015 | $715,000 | -79.5% | 86,469 | -79.6% | 0.01% | -81.8% |
| Q1 2015 | $3,489,000 | -39.3% | 423,372 | -49.4% | 0.06% | -36.8% |
| Q4 2014 | $5,746,000 | +30.4% | 836,416 | +2.5% | 0.09% | +27.9% |
| Q3 2014 | $4,406,000 | -10.1% | 815,845 | +6.0% | 0.07% | -9.3% |
| Q2 2014 | $4,901,000 | +61.9% | 769,421 | +104.9% | 0.08% | +47.1% |
| Q1 2014 | $3,027,000 | -54.7% | 375,573 | -61.6% | 0.05% | -49.5% |
| Q4 2013 | $6,675,000 | +116.2% | 978,746 | +483.4% | 0.10% | +71.2% |
| Q3 2013 | $3,087,000 | +261.9% | 167,779 | +243.9% | 0.06% | +181.0% |
| Q2 2013 | $853,000 | – | 48,793 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |